In terms of clinical practicability, emodin seems to attenuate the ischemia associated elevation of VEGF levels, which are widely accepted to possibly lead to ocular hemorrhage (increased vascular permeability) and macular edema (fluid leak). The gene discussed is VEGFA; the disease is ischemia.